Mtb is a robust activator of innate immunity, and innate immune activation of macrophages can affect its replication in vitro. However, the researchers noted that there had been little in vivo evidence that innate immunity controls Mtb before adaptive immunity develops. Earlier studies generally used specific-pathogen-free mouse models and relatively large infectious doses, potentially obscuring the ability of innate defenses to restrict infection.

To test whether smaller infectious doses revealed stronger early control, the investigators performed ultra-low-dose Mtb infections in mice. The initial innate immune response was unable to curb even the minimal infectious doses tested. Thus, the experiments did not find evidence that innate mechanisms established control of Mtb at the lowest challenge levels examined, although the result applies to the mice and experimental conditions used.

The researchers also examined whether prior exposure to a more diverse microbial environment changed susceptibility. They primed the immune systems of C57BL/6 mice by co-housing them with “pet shop” mice before Mtb exposure. The co-housed animals were as susceptible to Mtb infection as specific-pathogen-free mice, indicating that this form of immune priming did not provide measurable protection in the model.

A more targeted test involved infecting the lungs with Lp before Mtb exposure. Innate immunity alone can clear large Lp doses—more than 100,000 colony-forming units (CFU)—from the lung within a few days. Yet Lp pre-infection only modestly reduced Mtb CFU in mice subsequently infected with Mtb alone compared with those receiving Mtb without prior Lp infection. Single-cell RNA sequencing showed that Lp priming induced measurable changes in myeloid cells responding to Mtb, but those changes had little effect on innate control of the bacterium. Together, the results distinguish immune activation from effective bacterial clearance: a response capable of eliminating large amounts of Lp, and detectable changes in myeloid cells, did not substantially restrict Mtb replication. The study was limited to mouse infection models and did not determine how innate immunity contributes to tuberculosis in people or to the later course of infection involving adaptive immunity.

Subject of Research: Experimental assessment of innate immune control of Mycobacterium tuberculosis in mouse infection models

Article Title: Diverse infection models demonstrate robust resistance of Mycobacterium tuberculosis to innate immunity

Article References: Fairgrieve, M. R., Brydon, E. C., Chavez, R. A., Kotov, D. I., & Vance, R. E. (2026). Diverse infection models demonstrate robust resistance of Mycobacterium tuberculosis to innate immunity. PLOS Pathogens, 22(10), e1014713. https://doi.org/10.1371/journal.ppat.1014713

Image Credits: AI Generated

DOI: 10.1371/journal.ppat.1014713

Keywords: Mycobacterium tuberculosis, innate immunity, mouse models, ultra-low-dose infection, Legionella pneumophila, macrophages, myeloid cells, single-cell RNA sequencing, bacterial clearance, tuberculosis, Diverse, infection